SK Bioscience Co

SK Bioscience Co ROE

The Return on Equity (ROE) of SK Bioscience Co (302440.KS) as of Nov 22, 2026 is -3.21 %. In the previous year, Return on Equity (ROE) was -2.99 % — a change of 7.40% (lower).

ROE

-3.21 %

YoY

7.40%

Last updated:

In 2025, SK Bioscience Co's return on equity (ROE) was -3.21 %, a 7.40% increase from the -2.99 % ROE in the previous year.

The SK Bioscience Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
0.20 KRW
Jan 1, 2019
6.31 KRW
Jan 1, 2020
12.47 KRW
Jan 1, 2021
22.18 KRW
Jan 1, 2022
7.03 KRW
Jan 1, 2023
1.31 KRW
Jan 1, 2024
-2.99 KRW
Jan 1, 2025
-3.21 KRW
The SK Bioscience Co ROE history
YEARROEYoY
-3.21 %+7.40%
-2.99 %-328.21%
1.31 %-81.37%
7.03 %-68.30%
22.18 %+77.88%
12.47 %+97.70%
6.31 %+3,057.92%
0.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SK Bioscience Co Stock analysis

What does SK Bioscience Co do? SK Bioscience Co Ltd is a South Korean biotechnology company headquartered in Seongnam, Gyeonggi-Do. The company went public on March 18, 2021, with its stock listed on the Korean Stock Exchange under the ticker 302440.KS. It operates within the health care sector, specifically in the biotechnology industry. SK Bioscience employs 1,067 people and focuses on the development and distribution of bio and vaccine products. The company distributes its products both domestically and internationally. While specific product names are mentioned in unverified sources, the company is known to be involved in the production of vaccines and infusion solutions. It also engages in technology export business, though detailed information about its technology or export markets is not provided. The company's website is https://www.skbioscience.co.kr/, where further information about its operations and products may be available. SK Bioscience does not disclose specific details about its product lines beyond the general categories of vaccines and infusion solutions, and it does not provide information on acquisitions, founding year, or key personnel. The company's activities are centered around biotechnology and healthcare, with a focus on vaccine development and distribution. Its market presence spans both domestic and international markets, though specific regions or countries are not specified. The company's financial data, including revenue and market capitalization, is not included in the provided information. SK Bioscience is a publicly traded company with a focus on biotechnology and healthcare innovation. SK Bioscience Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding SK Bioscience Co's Return on Equity (ROE)

SK Bioscience Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing SK Bioscience Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

SK Bioscience Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in SK Bioscience Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about SK Bioscience Co stock

Return on Equity (ROE) of SK Bioscience Co is -3.21 % in 2025.

Return on Equity (ROE) of SK Bioscience Co changed from -2.99 % to -3.21 %, representing a 7.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) SK Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s SK Bioscience Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — SK Bioscience Co

All Key Metrics — SK Bioscience Co